FDA Inspection
Nomax IncNomax Inc – FDA Inspection, Mar 25, 2011
Record Details
This FDA Inspection record concerns Nomax Inc, with an inspection on March 25, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Nomax Inc
- Inspection Date
- March 25, 2011
- Product Type
- Drugs
View Company Profile
ID · f8f706b6-8f8a-4510-914a-719557401456
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 715969
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.166(a)Written program not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nomax Inc
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 25, 2026 | Not classified | Kansas City District Office | |
| February 16, 2024 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| December 2, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 24, 2022 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| February 1, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nomax Inc
- FDA Inspection 1315328 - 2026-02-25
- FDA Inspection 1229313 - 2024-02-16
- FDA Inspection 1194330 - 2022-12-02
- FDA Inspection 1180777 - 2022-06-24
- FDA Inspection 1042641 - 2018-02-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.